Cargando…

Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers

Interaction mapping is a powerful strategy to elucidate the biological function of protein assemblies and their regulators. Here, we report the generation of a quantitative interaction network, directly linking 14 human proteins to the AAA+ ATPase p97, an essential hexameric protein with multiple ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Arumughan, Anup, Roske, Yvette, Barth, Carolin, Forero, Laura Lleras, Bravo-Rodriguez, Kenny, Redel, Alexandra, Kostova, Simona, McShane, Erik, Opitz, Robert, Faelber, Katja, Rau, Kirstin, Mielke, Thorsten, Daumke, Oliver, Selbach, Matthias, Sanchez-Garcia, Elsa, Rocks, Oliver, Panáková, Daniela, Heinemann, Udo, Wanker, Erich E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080433/
https://www.ncbi.nlm.nih.gov/pubmed/27762274
http://dx.doi.org/10.1038/ncomms13047
Descripción
Sumario:Interaction mapping is a powerful strategy to elucidate the biological function of protein assemblies and their regulators. Here, we report the generation of a quantitative interaction network, directly linking 14 human proteins to the AAA+ ATPase p97, an essential hexameric protein with multiple cellular functions. We show that the high-affinity interacting protein ASPL efficiently promotes p97 hexamer disassembly, resulting in the formation of stable p97:ASPL heterotetramers. High-resolution structural and biochemical studies indicate that an extended UBX domain (eUBX) in ASPL is critical for p97 hexamer disassembly and facilitates the assembly of p97:ASPL heterotetramers. This spontaneous process is accompanied by a reorientation of the D2 ATPase domain in p97 and a loss of its activity. Finally, we demonstrate that overproduction of ASPL disrupts p97 hexamer function in ERAD and that engineered eUBX polypeptides can induce cell death, providing a rationale for developing anti-cancer polypeptide inhibitors that may target p97 activity.